Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 20777 | 385 | 26.5 | 44% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1196 | 8844 | BIOARTIFICIAL LIVER//LIVER REGENERATION//HEPATOCYTE TRANSPLANTATION |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ARTERIAL KETONE BODY RATIO | Author keyword | 20 | 59% | 6% | 23 |
| 2 | HEPATIC MITOCHONDRIAL REDOX STATE | Author keyword | 6 | 100% | 1% | 4 |
| 3 | ARTERIAL KETONE BODY RATIO AKBR | Author keyword | 4 | 75% | 1% | 3 |
| 4 | HEPATIC ENERGY METABOLISM | Author keyword | 3 | 50% | 1% | 5 |
| 5 | KETONE BODY RATIO | Author keyword | 3 | 39% | 2% | 7 |
| 6 | ARTERIAL BLOOD KETONE BODY RATIO | Author keyword | 3 | 60% | 1% | 3 |
| 7 | TEMPORARY VASCULAR OCCLUSION | Author keyword | 1 | 50% | 1% | 2 |
| 8 | HEPATIC ENERGY CHARGE | Author keyword | 1 | 33% | 1% | 3 |
| 9 | CENTRAL VENOUS BLOOD | Author keyword | 1 | 40% | 1% | 2 |
| 10 | MITOCHONDRIAL REDOX STATE | Author keyword | 1 | 15% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | KETONE BODY RATIO | 22 | 35% | 14% | 52 |
| 2 | ACETOACETATE BETA HYDROXYBUTYRATE | 11 | 78% | 2% | 7 |
| 3 | MITOCHONDRIAL REDOX STATE | 5 | 41% | 2% | 9 |
| 4 | BODY RATIO | 4 | 67% | 1% | 4 |
| 5 | BETA HYDROXYBUTYRATE RATIO | 4 | 75% | 1% | 3 |
| 6 | JAUNDICED RABBITS | 3 | 100% | 1% | 3 |
| 7 | PREDOMINANT ENERGY SUBSTRATE | 3 | 100% | 1% | 3 |
| 8 | MONOACETOACETIN | 2 | 50% | 1% | 3 |
| 9 | HEPATECTOMIZED PATIENTS | 2 | 40% | 1% | 4 |
| 10 | HUMAN LIVER TRANSPLANTATION | 1 | 15% | 2% | 9 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Overview of the effects of Ringer's acetate solution and a new concept: Renal ketogenesis during hepatic inflow occlusion | 2001 | 8 | 60 | 53% |
| ALTERATIONS IN MITOCHONDRIAL-FUNCTION AND MORPHOLOGY IN CHRONIC LIVER-DISEASE - PATHOGENESIS AND POTENTIAL FOR THERAPEUTIC INTERVENTION | 1993 | 33 | 174 | 11% |
| Purinergic signalling in the liver in health and disease | 2014 | 4 | 233 | 1% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CLIN MONCLOA | 1 | 33% | 0.5% | 2 |
| 2 | UNIDADE TRANSPLANTE HEPAT | 1 | 50% | 0.3% | 1 |
| 3 | ATATURK HLTH SCI | 0 | 33% | 0.3% | 1 |
| 4 | SYST BIOL HUMAN DIS | 0 | 25% | 0.3% | 1 |
| 5 | BIOL BIOQUIM BIOL MOL | 0 | 11% | 0.3% | 1 |
| 6 | TAMANAGAYAMA HOSP | 0 | 11% | 0.3% | 1 |
| 7 | GEN SURG LIVER DIS | 0 | 10% | 0.3% | 1 |
| 8 | INSERM UNITE RECH HEPATOL INFANTILE U56 | 0 | 100% | 0.3% | 1 |
| 9 | NEUROBIOL YAMASHIMA KU | 0 | 100% | 0.3% | 1 |
| 10 | PHARM HLTH SCI PHARMACOL TOXICOL | 0 | 100% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000153362 | L 3 HYDROXYBUTYRATE//FID GC FID//ACETOACETATE ESTERS |
| 2 | 0.0000117261 | HEPATIC OXYGEN DELIVERY//OP 2507//PGE1 |
| 3 | 0.0000111078 | LIVER REGENERATION//RAT GENOME 230 20 ARRAY//PARTIAL HEPATECTOMY |
| 4 | 0.0000107851 | PORTAL VEIN ARTERIALIZATION//AUXILIARY LIVER TRANSPLANTATION//AUXILIARY PARTIAL ORTHOTOPIC LIVER TRANSPLANTATION |
| 5 | 0.0000084367 | PORTAL VEIN EMBOLIZATION//FUTURE LIVER REMNANT//ALPPS |
| 6 | 0.0000082347 | LATE EVENING SNACK//NON PROTEIN RESPIRATORY QUOTIENT//BRANCHED CHAIN AMINO ACIDS |
| 7 | 0.0000078455 | HEPATIC AMINO NITROGEN CONVERSION//UREA SYNTHESIS//AMMONIOGENESIS |
| 8 | 0.0000077442 | BRAIN DEATH//THER EUT END STAGE ORGAN DYSFUNCT//DONOR MANAGEMENT |
| 9 | 0.0000074187 | MONOETHYLGLYCINEXYLIDIDE//MEGX//C 13 METHACETIN |
| 10 | 0.0000072899 | HEPATIC ISCHEMIA REPERFUSION INJURY//HEPATIC ISCHEMIA REPERFUSION//EXPT HEPAT I EMIA REPERFUS UNIT |